Combination therapies for HIV infection and genomic drug resistance

Lancet

Volumn 350, Issue 9083, 1997, Pages 970-971

  Katzenstein, D ^a  

^a STANFORD UNIVERSITY MEDICAL CENTER   (United States)

Author keywords

[No Author keywords available]

Indexed keywords

ANTIVIRUS AGENT; CD4 ANTIGEN; CHEMOKINE RECEPTOR; DELAVIRADINE; DIDANOSINE; INDINAVIR; LAMIVUDINE; NELFINAVIR; NEVARIPINE; PROTEINASE INHIBITOR; RITONAVIR; RNA DIRECTED DNA POLYMERASE; RNA DIRECTED DNA POLYMERASE INHIBITOR; SAQUINAVIR; STAVUDINE; UNCLASSIFIED DRUG; VIRUS RNA; ZALCITABINE; ZIDOVUDINE;

DISEASE COURSE; HUMAN; HUMAN IMMUNODEFICIENCY VIRUS INFECTION; LONG TERM CARE; LYMPHOCYTE COUNT; PATHOGENESIS; POINT MUTATION; PRIORITY JOURNAL; SHORT SURVEY; SURVIVAL; VIRUS GENOME; VIRUS MUTATION; VIRUS REPLICATION;

EID: 0030879281     PISSN: 01406736     EISSN: None     Source Type: Journal    
DOI: 10.1016/S0140-6736(97)22040-4     Document Type: Note

References (5)

1. DA Katzenstein SM Hammer M Hughes Virologic and immunologic markers and clinical outcomes after nucleoside therapy in adults with 200 to 500 CD4 cells per cubic millimeter: NIAID sponsored AIDS Clinical Trials Group Study 175, a virology substudy N Eng J Med 335 1996 1091 1098
2. JJ Eron SL Benoit Jemsek J Treatment with lamivudine, zidovudine or both in HIV-positive patients with 200-500 CD4+ cells per cubic millimeter N Engl J Med 333 1995 1662 1669
3. SM Hammer KE Squires Hughes MD A controlled trial of two nucleoside analogues plus indinavir in persons with human immunodeficiency virus infection and CD4 cell counts of 200 per cubic millimeter or less N Engl J Med 337 1997 725 732
4. M Dean M Carrington C Winkler Genetic restriction of HIV-1 infection and progression to AIDS by a deletion allele of the CKR5 structural gene Science 273 1996 1856 1861
5. CCJ Carpenter M Fischl SM Hammer Antiretroviral therapy for HIV Infection in 1997: Updated recommendations of an International AIDS Society-USA Panel JAMA 277 1997 1962 1969